Drug discovery company Therasis raises $12m | AltAssets Private Equity News

Subscribe today

Advanced
Search

Drug discovery company Therasis raises $12m

8 Dec 2009

Therasis Inc, a newly founded oncology drug discovery company, has secured $12m in a series A financing from Tilocor Life Science. The funds will allow the company to launch and further develop its proprietary oncology drug discovery engine, the Therasis Filter.

Sorry, to read the full story you must be a Premium Subscriber

Are you a subscriber?

In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.

Become a Premium Subscriber
for only £150 / €180 / $225 p.a.

Login area

If you are already a AltAssets subscriber please log in below.